Kangmei Pharmaceutical Co Ltd operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kangmei Pharmaceutical Co Ltd with three other
companies in this sector in China:
Apeloa Pharmaceutical Co Ltd
sales of 4.34 billion Chinese Renmimbi [US$628.50 million]
of which 100%
was Health Care & Pharmaceutical),
Guangzhou Baiyunshan Pharmaceutical Stock
(18.96 billion Chinese Renmimbi [US$2.75 billion]
China Resources Double-Crane Pharmaceutical Company Limited
(5.14 billion Chinese Renmimbi [US$744.32 million]
of which 52%
Kangmei Pharmaceutical Co Ltd reported sales of 18.03 billion Chinese Renmimbi (US$2.61 billion)
December of 2015.
increase of 13.3%
versus 2014, when the company's sales were 15.92 billion Chinese Renmimbi.
Sales at Kangmei Pharmaceutical Co Ltd have increased during each of the previous five years
(and since 2010, sales have increased a total of 445%).
Sales of Food saw an increase
that was more than double the company's growth rate: sales were up
60.0% in 2015, from
879.54 million Chinese Renmimbi to 1.41 billion Chinese Renmimbi.